Growth Hormone Secretagogue Receptor Agonists [MoA] - N0000193786
Pharmacologic Class Information
| Pharmacologic Code | N0000193786 |
| Pharmacologic Name | Growth Hormone Secretagogue Receptor Agonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Growth Hormone Secretagogue Receptor Agonists
The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Growth Hormone Secretagogue Receptor Agonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0169-1401 | Macrilen | Non-Proprietary Name: Macimorelin Acetate | Granule, For Solution | Oral | Novo Nordisk | ACTIVE | |
| 71090-002 | Macrilen | Non-Proprietary Name: Macimorelin Acetate | Granule, For Solution | Oral | Strongbridge U.s. Inc | ACTIVE |